Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Bu Fei Jian Pi Hua Tan is a polyherbal Traditional Chinese Medicine (TCM) formulation, typically prepared as a granule, used for the treatment and rehabilitation of respiratory disorders. Its name translates to therapeutic principles: 'Bu Fei' (tonifying the lung), 'Jian Pi' (strengthening the spleen), and 'Hua Tan' (resolving phlegm). It is primarily developed for patients with 'Lung-Spleen Qi Deficiency' syndrome, a common clinical presentation in elderly patients recovering from Community-Acquired Pneumonia (CAP) or those suffering from Chronic Obstructive Pulmonary Disease (COPD). The formula aims to improve respiratory function, modulate immune response, and reduce systemic and local airway inflammation, thereby reducing rehospitalization rates and improving overall quality of life.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Bu Fei Jian Pi Hua Tan.